Menu

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6103812)

E IFA RE 15 Permethrin 5 WW Tube Of 30 Gm,E IFA RE 15 Permethrin Lotion 5 percent bottle of 60ml,E

Goods
Qty:2.4L
EMD: ₹699
EST Bid: ₹11.1 Lakh
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6103812)

Tender Timeline

Tender Issue
April 9, 2025 at 7:31 PM

Tender Title and Reference Number

DRUGS AND PHARMACEUTICALS
Reference Number: GEM/2025/B/6103812

Issuing Authority/Department

This tender is issued by the Department of Military Affairs, under the Ministry of Defence.

Scope of Work and Objectives

The primary objective of this tender is to procure a total quantity of 241,706 units of specific pharmaceutical products, which include:

  • E IFA RE 15 Permethrin 5 WW Tube of 30 grams
  • E IFA RE 15 Permethrin Lotion 5 percent in a bottle of 60ml

The successful vendor will ensure that the supplied products meet all defined pharmaceutical standards and quality requirements, aiding in the effective implementation of health and preventive care programs within military operations.

Eligibility Criteria

To qualify for this tender, bidders must:

  • Be a registered entity and comply with applicable legal and regulatory frameworks.
  • Ensure that they possess all necessary certifications related to pharmaceuticals, which can demonstrate their capability to manufacture or supply the specified drugs.
  • Provide evidence of meeting the technical specifications and quality assurance standards as outlined by the issuing department.

Technical Requirements

The technical specifications for the required Permethrin products will include:

  • Compliance with established health regulations.
  • Meeting specific pharmaceutical quality standards to ensure safety and effectiveness.
  • Adequate documentation indicating the manufacturing and quality assurance processes.

Financial Requirements

Bidders must demonstrate financial stability and capability to complete the contract successfully. This will typically require:

  • Submission of financial statements.
  • Proof of creditworthiness or a bank guarantee.
  • Adherence to tender pricing formats and conditions as specified in the submission documents.

Document Submission Details

Bidders are required to submit their proposals and supporting documents electronically, adhering to the following conditions:

  • All submissions must be made through the designated online portal.
  • Bidders must ensure compliance with document format specifications outlined in the tender guidelines.

Special Provisions

Aiming to support Micro, Small, and Medium Enterprises (MSEs), this tender encourages participation from such entities by providing incentives or preferential considerations during the evaluation process.

Evaluation Process

The evaluation of bids will be conducted based on a comprehensive assessment of technical capabilities and financial viability. Factors considered will include:

  • Conformity with the technical requirements.
  • Cost-effectiveness.
  • Compliance with quality standards.
  • Past performance, including timely delivery and service quality.

Delivery Locations

Delivery of the products will be required at designated military facilities. Specific addresses and logistical details will be provided upon selection of successful bidders.

Contact Information

For inquiries related to this tender, please refer to the official communication channels provided on the designated tender portal for accurate and timely responses.

Conclusion

This is an essential procurement aimed at enhancing military healthcare provisions through the acquisition of high-quality pharmaceuticals. Potential bidders are encouraged to carefully review all requirements and submit their applications fully compliant with the tender guidelines to ensure eligibility.


General Information

Item Category
E IFA RE 15 Permethrin 5 WW Tube Of 30 Gm , E IFA RE 15 Permethrin Lotion 5 percent bottle of 60ml , E IFA RE 15 Phenytoin Sodium Er 300 Mg Tab , E IFA RE 15 Phosphate Enema 100 ML , E IFA RE 15 Pioglitazone 30Mg Tab , E IFA RE 15 Piracetam 400 Mg Tab , E IFA RE 15 Piracetam 800 Mg Tab , E IFA RE 15 Piroxicam 20Mg Tab , E IFA RE 15 Povidone Iodine 10 Oint , E IFA RE 15 Povidone Iodine Gargle Betadine , E IFA RE 15 Povidone Iodine Solution 5 Bottle Of 100 Ml , E IFA RE 15 Povidone Iodineip 5 WW Tube Of 15 Gm , E IFA RE 15 Powder Clotrimazole 75 Gm , E IFA RE 15 Pramipexole 1 Mg Tab , E IFA RE 15 Prasugrel 10 Mg Tab , E IFA RE 15 Prednisolone 10Mg Tab , E IFA RE 15 Pregabalin 50 Mg Tab , E IFA RE 15 Pregabalin 75 Mg Nortriptyline 10 Mg Methylcobalamin 1500 Mcg Tab , E IFA RE 15 Pregabalin 75 Mg Ntp 10 Mg Tab , E IFA RE 15 Pregabalin 75Mg Methylcobalamin 750 Mg Tab , E IFA RE 15 Pregabalin Sr 75 Mg Tab , E IFA RE 15 Pregnancy Test Kit , E IFA RE 15 PrePro Tab Probiotic , E IFA RE 15 Prochlorperazine Maleate 5 Mg Tab Stemetil , E IFA RE 15 Propranolol 10 Mg Tab Inderal , E IFA RE 15 Protein Powder , E IFA RE 15 Prucalopride 1 Mg Tab , E IFA RE 15 Prucalopride 2 Mg Tab , E IFA RE 15 Pulv Protein Supplement Formula For Renal Patient 200 Gm Container , E IFA RE 15 Pyrazinamide 500Mg Tab , E IFA RE 15 Quetiapine 25 Mg Tab , E IFA RE 15 Rapid Test Kit for RDOTA Factor , E IFA RE 15 Rabeprazole 20 Mg Tab , E IFA RE 15 Rabeprazole 20Mg Domeperidon 10Mg Tab , E IFA RE 15 Rabeprazole 40 Mg Tab , E IFA RE 15 Racecadotril 100 Mg Cap , E IFA RE 15 Ramipril 1DOT25 Mg Tab , E IFA RE 15 Ranitidine Hcl 50 Mg Amp 2 Ml Inj , E IFA RE 15 Ranolazine Sr 500 Mg Tab , E IFA RE 15 Rasagiline 0DOT5 Mg Tab , E IFA RE 15 Rasagiline 1 Mg Tab , E IFA RE 15 Remogliflozin 100Mg Tab , E IFA RE 15 Repaglinide 0DOT5 Mg Tab , E IFA RE 15 Repaglinide 1Mg Tab , E IFA RE 15 Repaglinide 2 Mg Tab , E IFA RE 15 Respule Levosalbutamole 1DOT25 Mg , E IFA RE 15 Rib Support Belt , E IFA RE 15 Rifampicin 600Mg Tab , E IFA RE 15 Rifaximine 400Mg Tab
Ministry Name
Organisation Name

Financial Information

Estimated Bid Value
₹11,09,263.00
EMD Amount
₹699.00
Bid Offer Validity
180 (Days)
Past Performance
80 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

6 Documents
GeM-Bidding-7699646.pdfMain Document
Other DocumentsOTHER
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Ivermectin 12 mg Tab,Corn Cap 40 percent Sallicylic Acid,Miconazole Nitrate 2 percent Ung 15 gm,Cap

GEM
Goods
Qty:29.3K
4 Files
Indian Army
AMBALA, HARYANA
Boq › Boql
Ivermectin 12 mg Tab , Corn Cap 40 percent Sallicylic Acid , Miconazole Nitrate 2 percent Ung 15 gm , Cap Minocycline ER 65 mg , Hydrous Benzoyl Peroxide IP FACE WASH 4 percent of 50 , Clindamycin 1 percent w v Benzoyl peroxide 5 percent w w , Clindamycin 1 percent plus Nicotinamide 4 percent 20 gm tube , Clobetasol Propionate 0 point 05 percent plus Buffered lactic acid , Cyclophosphamide 500 mg Inj , Gel Luliconazole 1 percent with Sepineo and Biochitoderm , Halobetasol proprionate 0 point 05 percent cream 50 gm , Hydrocortisone Acetate Cream 1 percent Tube of 15 gm , Inj Bleomycin Sulphate 15 Units , inj Triamcinolone Acetate 10Mg ml , Lot Clotrimazole 1 percent plus Beclomethasone 0 point 0 , Lot Minoxidil 10 percent Bott of 60ml , 50 precent Glycolic acid Peel 60ml with Pre Peel liposomal , Aloevera 10 point 0 percent Vitamin E 0 point 5 percent , Azelaic Acid 20percent Cream Tube of 15 gm , Mometasone Lotion 0 point 1 percent Tube of 15ml , PRP kit , Tab Minoxidil 2 point 5 mg , Tacrolimus ointment 0 point 03 percent Tube of 20 gram , Tretinoin gel 0 point 025 percent tube of 20 gram , Yellow Peel Kit 10 percent Ascorbyl Glucoside and 5 percent , Zinc Oxide and Benzalkonium chloride cream tube of 30 gram , 0 point 1 percent Triamcinolone Acetonide Bucccal Parts , White Soft Paraffin ,Light Liquid Paraffin,Light Liquid Paraffin , Ivermectin 6mg Tab , Luliconazole 1 percent Cream 30gm , Minoxidil 2 percent Lotion 60 ml , Methotrexate LP Liposomal topical gel 1 percent Tube , Minoxidil 5 percent wv plus Finasteride 0 point 1 , Bilastine 10 mg Tab , Ketoconazole 2 percent and Salicyclic acid 2 percent , Tab Fluconazole 400 mg Tab , Ciclopiroxolamine 1 percent Cream 30gm , Deca Peptide Solution of 2 ml , Triamcinolone Acetonide 40mg Inj , Lot lacquer nail amorlfine 5 percent 2 point 5ml , Disposable skin biopsy punches size 5 mm , Disposable skin biopsy punches size 6 mm , 0 point 4 percent Tretinoin Microsphere gel Tube of 20 gm , Ciclopirox 1 percent Zinc Pyrithidone 1 percent , Clotrimazole 1 percent plus Selenium Sulphate 2 point 5 percent , Lactic Acid 17 percent Salicylic Acid 17 percent isopropyl alcohol , Amorolfine 0 point 25percent Ung 20 gm , Imiquimod 5percent Ung , Adapalene 0 point 1 percent Tube of 15 gm , Tacrolimus Oint 0 point 1 percent 20 gm tube , Benzoyl Peroxide 2 point 5 percent Tube of 20 gm , Lot Octinoxate 7 point 5 percent plus Oxybenzone 3 percent plus , Disposable Miniature Punches Size 3 mm , Disposable miniature punches size 4 mm , Ung Kojic acid 3percent vit c 15gm , Clindamycin phosphate 1 percent topical gel Tube of 10 gm , Fluticasone 0 point 05percent oint Tube of 10 gm , Permethrin 5 percent Tube of 30 gm , Podophyllin Resin 20 percent bott of 10 ml , Halobetasol proprionate lotion 0 point 05 percent , Eberconazole Ung 30 gm , Fluocinolone acetonide 0 point 01 percent Hydroquinone , Valacyclovir 1gm Tab , Tofacitinib 2 percent cream tube of 30 gm
April 25, 2025
May 16, 2025 at 11:00 AM
View Details

D IFA RE 19 Procarbazine HCl 50mg Cap,D IFA RE 19 Thalidomide 50mg Cap,D IFA RE 19 Methotrexate 5 m

₹161.00
GEM
Goods
Qty:51K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 19 Procarbazine HCl 50mg Cap , D IFA RE 19 Thalidomide 50mg Cap , D IFA RE 19 Methotrexate 5 mg Tab , D IFA RE 19 Ondansetron 8 mg Tab , D IFA RE 19 Goserelin 3 DOT 6 mg Prefilled Syringe , D IFA RE 19 Omalizumab 150 mg solution for injection in each 1 ml Pre Filled Syringe PFS , D IFA RE 19 Selegiline HCl 5mg Tab , D IFA RE 19 Rasagiline 1mg Tab , D IFA RE 19 Trihexyphenidyl HCl 2 mg Tab , D IFA RE 19 Topiramate 50mg Tab , D IFA RE 19 Pregabalin 75mg Tab , D IFA RE 19 Recombinant Human Tissue type Plasminogen Activator tPA powder for injection 20 mg Altiplase , D IFA RE 19 Erythropoitein Human Recombinant 20000 IU Inj , D IFA RE 19 Acenocoumarol 4 mg Tab , D IFA RE 19 Choline Salicylate and Benzalkonium chloride gel of 10 ml , D IFA RE 19 Diltiazem 60 mg Tab , D IFA RE 19 Isosorbide Mononitrate 20 mg Tab , D IFA RE 19 Glyceryl Trinitrate CR 2 DOT 6 mg Tab , D IFA RE 19 Simvastatin 20mg Tab , D IFA RE 19 Enalapril Maleate 10 mg Tab , D IFA RE 19 Enalapril Maleate 2 DOT 5 mg Tab , D IFA RE 19 Ramipiril 2 DOT 5 mg Tab , D IFA RE 19 Digoxin 0 DOT 25 mg Tab , D IFA RE 19 Verapamil Sustained Release 120mg Tab , D IFA RE 19 Telmisartan 40 mg Amlodipine 10 mg Tab , D IFA RE 19 Telmisartan 40 mg Amlodipine 10 mg Hydrochlorothiazide 12 DOT 5 mg Tab , D IFA RE 19 Macitentan 10mg Tab , D IFA RE 19 Hydrochlorothiazide 25mg , D IFA RE 19 Ramipiril 5 mg Hydrochlorothiazide 12 DOT 5 mg Tab , D IFA RE 19 Metoprolol 12 DOT 5 mg Tab , D IFA RE 19 Nebivolol 50 mg Tab , D IFA RE 19 Levosimendan 12 DOT 5gm Inj , D IFA RE 19 Antiseptic mouth wash containing Sodium fluoride and triclosan bott of 100 150ml , D IFA RE 19 Anticaries Fluoride Rinse Mouth wash with sodium fluoride acidulated phosphate bott of 300 500 ml , D IFA RE 19 Zinc Oxide Titanium Dioxide Bott SPF 50 Sunscreen lotion Bottle of 60 ml , D IFA RE 19 Triamcinolone Acetonide 0 DOT 1 for oral use tube of 5 gm , D IFA RE 19 Adapalene 0 DOT 1 Tube of 15 gm , D IFA RE 19 Tacrolimus Oint 0 DOT 03 20gm tube , D IFA RE 19 Calamine 8 with 10 Light Liquid Paraffin 50ml bott , D IFA RE 19 Betamethasone Dipropionate USP 0 DOT 05mg and Gentamycin Sulphate 1mg gm tube of 5gm , D IFA RE 19 Calamine Powder , D IFA RE 19 Octinoxate avobenzone oxybenzone and zinc oxide lotion SPF 15 or more 50 ml bottle , D IFA RE 19 Clindamycin Phosphate 1 topical gel Tube of 10 gm , D IFA RE 19 Dithranol 1 to 2 with without coal tar Salicylic Acid 1 2 oint Tube of 30 gm , D IFA RE 19 Fluticasone 0 DOT 05 w w cream 10gm tube , D IFA RE 19 Liquor Formaldehyde 40 w v , D IFA RE 19 Glycerin Glycerol in bottle of 1 Kg
April 22, 2025
May 14, 2025 at 11:00 AM
View Details

D IFA RE 17 Ropivacaine 5 mg ml 20 ml Amp Inj,D IFA RE 17 Ketamine HCl 50 mg ml 2ml Inj,D IFA RE 17

GEM
Goods
Qty:15K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 17 Ropivacaine 5 mg ml 20 ml Amp Inj , D IFA RE 17 Ketamine HCl 50 mg ml 2ml Inj , D IFA RE 17 Epinephrine 1 10 000 1 mg in 10 ml PFS of 10 ml Inj , D IFA RE 17 Lignocaine Viscous 2 containing Lignocaine 21 DOT 3 mg Methyl Paraben 0 DOT 61 mg Propyl Paraben 0 DOT 27 mg ml in bott of 100ml , D IFA RE 17 Lignocaine HCl 2 without Adrenaline 30 ml Inj suitable for phthalmic use also , D IFA RE 17 Lignocaine HCl 2 with Adrenaline 1 80000 30 ml Inj , D IFA RE 17 Liquid Gelofusine bottle of 500 ml , D IFA RE 17 Lidocaine Lignocaine HCl 2 with Adrenaline epinephrine 1 80000 1 DOT 8 ml cartridge , D IFA RE 17 Laryngeal Tube Suction LTS II Size 4 Adult Medium , D IFA RE 17 Atropine Sulphate 0 DOT 6mg Inj 1ml Amp , D IFA RE 17 Peracetic Acid Bott of 810 gm , D IFA RE 17 2 Propanol 1 Propanol Macetronium Ethylsulphate 0 DOT 2 45 gm 30gm in 100 gm , D IFA RE 17 Iso propanol 60 65 and Benzalkonium Chloride Skin Disinfectant 63gm 0 DOT 025 gm in 100 gm , D IFA RE 17 1 6 Dihydroxy 2 5 Dioxahexane Gluteraldeyde Benzylalkonium chl Alkyl Urea derivative 11 DOT 2gm 5 DOT 0gm 5gm 3gm in 100 gm , D IFA RE 17 Aceclofenac 100 mg Paracetamol 500 mg Tab , D IFA RE 17 Diclofenac Sodium SR 100 mg Tab , D IFA RE 17 Indicator Soda lime , D IFA RE 17 Common Cold Tab containing Cetirizine 5 10 mg Paracetamol 500 mg Pseudoephedrine 30 60 mg , D IFA RE 17 Deflazacort 6 mg Tab , D IFA RE 17 Ibuprofen Syrup 100 mg 5 ml Bott of 50 ml , D IFA RE 17 Etoricoxib 120 mg Tab , D IFA RE 17 Piroxicam 40 mg 2 ml Inj , D IFA RE 17 Pethedine 50 mg 1 ml Inj , D IFA RE 17 Tizanidine 2 mg Ibuprofen 400 mg Tab , D IFA RE 17 Aceclofenac 100 mg Tab , D IFA RE 17 Betamethasone 4 mg 1ml Inj , D IFA RE 17 Adrenaline Tartrate 1 1000 1 ml Inj , D IFA RE 17 Suspension Syp Fexofenadine 30 mg 5ml 60 ml bottle , D IFA RE 17 Promethazine Syp 5 mg 5 ml bott of 60 ml , D IFA RE 17 Terbutaline Sulphate 0 DOT 5 mg 1ml Inj , D IFA RE 17 Hydrocortisone Acetate 25 mg ml 5 ml Inj , D IFA RE 17 Pheniramine Maleate Inj 22 DOT 75 mg ml amp of 2 ml , D IFA RE 17 Levetiracetam 100 mg ml Inj vial of 5 ml , D IFA RE 17 Pyridostigmine Bromide ER 180mg Tab , D IFA RE 17 Pramipexole 0 DOT 25mg Tab , D IFA RE 17 Levetiracetam 100 mg ml Syr Soln Liquid , D IFA RE 17 Carbamazepine syp 100 mg 5 ml bottle of 100 ml , D IFA RE 17 Diazepam Syp 2 mg 5 ml bottle of 60 ml , D IFA RE 17 Diazepam 5 mg Tab , D IFA RE 17 Fosphenytoin 75 mg ml Inj 2ml ampoule , D IFA RE 17 Phenytoin oral suspension containing Phenytoin 100 mg 4 ml bottle of 100 ml , D IFA RE 17 Daclatasvir 60 mg , D IFA RE 17 Sodium Valproate oral solution 200 mg 5ml Bott of 100 ml , D IFA RE 17 Sumatriptan Nasal Spray 20 mg 10 metered doses , D IFA RE 17 Topiramate 25 mg Tab , D IFA RE 17 Nimodipine 30mg Tab
April 22, 2025
May 14, 2025 at 11:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, compliance with regulatory and licensing norms for pharmaceutical suppliers, and possession of necessary quality and manufacturing certifications. Companies must provide adequate documentation to demonstrate their capability to meet the technical specifications and must not have any disqualifications or pending legal issues. Additionally, preference may be given to Micro, Small, and Medium Enterprises (MSEs) as stipulated by the issuing authority.

The technical specifications for the pharmaceuticals include adherence to established health and safety protocols regulated by the authorities. This encompasses having quality assurances that align with pharmaceutical standards. Bidders must present detailed manufacturing processes, quality control tests, and documented compliance with safety norms, ensuring that the provided products are effective and safe for military use.

The payment terms will typically be structured upon delivery and acceptance of the goods, with specific conditions outlined in the tender documentation. An Earnest Money Deposit (EMD) may be required at the time of submission to secure the bid. This amount acts as a financial commitment and is often refundable upon successful contract execution or participation withdrawal within the guidelines.

The submission process for this tender will occur through the designated online procurement platform. Bidders must ensure that their submissions follow the specific document formats provided in the tender guidelines. It will include uploading necessary supporting documents and completion of online bidding forms, ensuring all entries are completed accurately to comply with the evaluation criteria.

Yes, the tender provisions include incentives for startups under the government initiatives to promote new businesses. Startups can benefit from relaxed eligibility requirements and preferences during the evaluation of bids, as part of efforts to enhance participation from innovative and emerging industries in the procurement process. Compliance with ‘Make in India’ policies can further enhance the bidding position.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders